Sauvage Philippe
Chief Financial Officer
Sauvage Philippe has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
On the most recent filing, Sauvage Philippe is listed as Chief Financial Officer at Nuvation Bio Inc. Inside the rolling window, Sauvage Philippe reported no open-market purchases and 1 open-market sale totaling $286K in NUVB.
Companies traded
Other insiders at NUVB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$286K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sauvage Philippe made?
Sauvage Philippe has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Sauvage Philippe trade?
Sauvage Philippe has filed SEC Form 4 disclosures for 1 company, including NUVB.
When was Sauvage Philippe's most recent SEC Form 4 filing?
Sauvage Philippe's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.
What is Sauvage Philippe's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sauvage Philippe is listed as Chief Financial Officer.
What is Sauvage Philippe's total buy and sell value in the current window?
Inside the rolling retention window, Sauvage Philippe bought $0 and sold $286K based on SEC Form 4 filings.
What was Sauvage Philippe's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 47,668 NUVB shares on 2026-06-23, worth $286K, per SEC Form 4 filings.